HomeSNPHF • OTCMKTS
add
Santen Pharmaceutical Co Ltd
Nakaraang pagsara
$10.53
Sakop ng taon
$9.26 - $12.46
Market cap
487.08B JPY
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (JPY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 76.37B | -0.85% |
Gastos sa pagpapatakbo | 30.91B | -8.61% |
Net na kita | 8.69B | 18.56% |
Net profit margin | 11.38 | 19.54% |
Kita sa bawat share | — | — |
EBITDA | 15.83B | 0.55% |
Aktuwal na % ng binabayarang buwis | 24.64% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (JPY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 77.85B | -5.09% |
Kabuuang asset | 398.31B | -6.90% |
Kabuuang sagutin | 115.10B | -11.35% |
Kabuuang equity | 283.21B | — |
Natitirang share | 341.35M | — |
Presyo para makapag-book | 0.01 | — |
Return on assets | 7.01% | — |
Return on capital | 9.91% | — |
Cash Flow
Net change in cash
| (JPY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 8.69B | 18.56% |
Cash mula sa mga operasyon | 13.73B | -56.70% |
Cash mula sa pag-invest | -2.77B | -42.37% |
Cash mula sa financing | -20.22B | -73.43% |
Net change in cash | -6.59B | -138.09% |
Malayang cash flow | 9.01B | -68.47% |
Tungkol
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
Itinatag
1890
Headquarters
Website
Mga Empleyado
3,744
